Actavia Life Sciences, Inc. (OTCPK: RASP)
Health Care · Biotechnology · US
$—
— today · — 1Y
Actavia Life Sciences, Inc. (OTCPK: RASP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $385.91K and employs 1 people.
trading between 0.00 and 0.01.
Tweenvest scores Actavia Life Sciences, Inc. across four factors: quality 16/100. Its strongest factor is quality.
RASP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $385.91K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- -81.78
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 771.81M
- Employees
- 1
- Next earnings
- —
About Actavia Life Sciences, Inc.
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
- ISIN
- US7538881068
- Founded
- 2013
- Listed since
- Feb 24, 2015
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.